The lancet oncology
-
The lancet oncology · Jul 2015
Randomized Controlled Trial Comparative StudyPalbociclib for hormone receptor-positive breast cancer.
-
The lancet oncology · Jul 2015
Randomized Controlled TrialMismatch repair deficiency predicts benefit of anti-PD-1 therapy.